GPC3 and hepatocellular carcinoma: Glypican-3 (GPC3), as a cell surface heparan sulfate proteoglycan, is a valuable therapeutic target and a promising diagnostic biomarker because of its highly specific expression at the plasma membrane of HCC cell lines but not in the normal adult liver tissue (Nakatsura et al., 2003; Yamauchi et al., 2005).